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hyperinsulinemia and ameliorates the response to
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Background: Consuming a fructose-rich diet leads to hyperinsulinemia, impaired glucose tolerance, and insulin
resistance. In humans, the consumption of high levels of refined sugars often coincides with a diet containing
suboptimal levels of calcium. Calcium and carbohydrate metabolism interact, so there is potential for fructose to
have different health outcomes depending on whether the diet is calcium-rich or calcium-poor.
Methods: We evaluated the metabolic effects of feeding fructose to rats that were maintained on either a
calcium-replete diet or a low-calcium diet. Growing male Sprague Dawley rats were fed diets based on the
AIN-93G formulation, with the main source of carbohydrate derived either from a mixture of cornstarch and
sucrose or from fructose. Half the rats given each carbohydrate source were fed calcium at recommended
levels (125 mmol/kg Ca2+); the others were fed a diet low in calcium (25 mmol/kg Ca2+). At various times,
glucose and insulin tolerance tests were conducted to assess glucose metabolism.
Results: Rats fed low-calcium diet had lower fasting insulin levels irrespective of the carbohydrate source
they ate. They had a normal glycemic response to a glucose load and did not develop hyperinsulinemia
under conditions of fructose feeding. The drop in blood glucose levels in response to insulin injection was
larger in rats fed low-calcium diet than in those fed calcium-replete diet.
Conclusions: Low-calcium diet prevented fructose-induced hyperinsulinemia and improved glucose handling
under conditions of fructose feeding. Potential mechanisms underlying these effects of the low-calcium diet
remain to be determined, but possibilities include impairment of insulin release from the pancreas and
improved peripheral insulin sensitivity.
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Diet has a major impact on metabolic health, and is a pri-
mary factor implicated in metabolic syndrome and Type 2
diabetes [1, 2]. The drive for energy-dense foods often
leads to diets high in sugary drinks and snacks, resulting
in high intakes of refined sugars and suboptimal intakes of
micronutrients, such as calcium. The deleterious effects of
excess consumption of simple sugars on carbohydrate me-
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stated.both the quantity and the type of sugar consumed [2–4].
Due to a general increase in sweetener usage during the
last decades of the 20th century, and the popularity of
high-fructose corn syrups, fructose consumption in the
USA has risen by over 25 % [5, 6], although intakes may
have decreased slightly in the last few years [7].
Fructose is a simple sugar contained in many food
items, either by itself or as a part of the sucrose molecule.
Diets rich in fructose induce impaired glucose tolerance
accompanied by insulin resistance and hyperinsulinemia
[8]. The mechanism underlying fructose-induced meta-
bolic syndrome is complex. It is most likely initiated when
fructose induces sustained hepatic gluconeogenesis and
lipogenesis, because it bypasses the major regulatory stepscess This article is distributed under the terms of the Creative Commons
ativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
u give appropriate credit to the original author(s) and the source, provide a link
e if changes were made. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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the liver is thought to also induce insulin resistance
in the periphery, followed by compensatory hyperin-
sulinemia [6, 10].
The progressive increase in intake of high-fructose
corn syrup is related to the rise in the consumption of
soft drinks, for which it is the main sweetener (e.g.,
[11]). One other major consequence of the increased
intake of sweetened soft drinks is the displacement of
milk from the diet [12]. Milk is an important source of
calcium, so its disappearance from the diet has exacer-
bated suboptimal calcium intakes [12, 13]. Calcium
deficiency leads to impaired insulin release in experi-
mental animals, and there are indications that the same
is true for humans [14–16]; decreases in circulating
levels of both calcium and vitamin D are associated with
changes in glucose homeostasis [17–19]. Thus, calcium
and sugar intake, and their homeostasis are intertwined;
however, little is known about how calcium status influ-
ences the regulation of metabolism under conditions of
sugar overconsumption.
We investigated whether the combination of a high-
fructose diet along with marginally inadequate calcium
might have combined detrimental influences on glucose
metabolism. To this end, we compared the metabolic
profiles of rats fed diets with the carbohydrate provided
either as a standard mixture of cornstarch and sucrose
or as fructose, and with the calcium provided either
at replete or marginally deficient levels. We found
that relative to calcium-replete controls, rats fed
low-calcium diet had improved insulin sensitivity andTable 1 Composition of experimental diets
AIN125 AIN2
Ingredient kcal/g g/kg kcal/kg g/kg
Casein 3.58 200 716 200
L-Cystine 4 3 12 3
Fructose 3.8 0 0 0
Sucrose 4 100 400 100
Cornstarch 3.6 385 1386 395
Dyetrose 3.8 132 501.6 132
Soybean oil 9 70 630 70
t-Butylhydroquinone 0 0.014 0 0.01
Cellulose 0 50 0 50
Mineral Mix #213019
(w/o Ca)
0.88 35 30.8 35
Vitamin Mix # 310025 3.87 10 38.7 10
Choline bitartrate 0 2.5 0 2.5
Calcium carbonate 0 12.5 0 2.5
Total kcal per kg 3715
All diets were purchased from Dyets Inc, Bethlehem, PA (catalogue nos: 103660, 10
cornstarch used to facilitate pelleting the diet. The mineral and vitamin mixes yielddid not develop hyperinsulinemia when fed the high-
fructose diet.
Methods
The experiment involved a 2 × 2 design: Rats were fed di-
ets containing either 125 or 25 mmol/kg Ca2+, with the
carbohydrate source derived from either a standard
sucrose-cornstarch mixture or from fructose. Blood sam-
ples were collected at various times, as described below.
The protocol was approved by the Monell Chemical
Senses Center Institutional Animal Care and Use
Committee.
Subjects
Two identical cohorts of 36 rats each (72 total) were
tested. Male Sprague–Dawley rats were obtained from
Charles River (Raleigh, NC) at the age of 21 days. They
were housed individually in stainless steel wire mesh
hanging cages (19.5 × 17.5 × 24 cm). Unless otherwise
noted, pelleted AIN-93G diet modified to contain
125 mmol Ca2+/kg (Table 1) and deionized water were
provided ad libitum. The vivarium was maintained at
23 °C on a 12:12 h light/dark cycle with lights off at
19:00 and on at 07:00.
Diets
The composition of the four experimental diets is shown in
Table 1. AIN-93G diet is a diet recommended by the
American Institute of Nutrition (now the American Society
for Nutrition) in 1993 for growing rats. It contains approxi-
mately 10 % sucrose and 52 % cornstarch by weight5 FRU125 FRU25
kcal/kg g/kg kcal/kg g/kg kcal/kg
716 200 716 200 716
12 3 12 3 12
0 617 2345 627 2383
400 0 0 0 0
1422 0 0 0 0
501.6 0 0 0 0
630 70 630 70 630
4 0 0.014 0 0.014 0
0 50 0 50 0
30.8 35 30.8 35 30.8
38.7 10 38.7 10 38.7
0 2.5 0 2.5 0
0 12.5 0 2.5 0
3751 3772 3810
3662, 103661, 103663, respectively). Dyetrose is a proprietary dextrinized
energy because they are mixed in a powdered sucrose base
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93G-based diets except that virtually all the carbohydrate
was provided as fructose (small amounts of sucrose were
used as a vehicle for the mineral and salt mixes). These
were provided in either “replete” (125 mmol/kg) or “low”
(25 mmol/kg) calcium concentrations. The 125 mmol/kg
calcium concentration is well above requirements for
growth [20, 21]. The 25 mmol/kg calcium concentration
was chosen based on our previous work showing that it
effectively reduced blood calcium concentrations and
induced the motivation to consume calcium but it did not
cause a failure to thrive (e.g., [22, 23]). For convenience, we
abbreviate the diets based on their carbohydrate source
[i.e., similar to AIN-93G or fructose (FRU)] and the
concentration of calcium (125 or 25 mmol/kg).Procedures
After 3 days to acclimatize to the vivarium environment,
the rats were assigned to four groups matched for body
weight and the percentage of body weight that was fat,
which was assessed using a Bruker Minispec nuclear mag-
netic resonance analyzer (see below). The experimental
diets were introduced in two steps: On Day 0 (at age
24 days), half of the rats were switched to AIN25 diet; the
other half remained on AIN125 diet. On Day 3, half of the
rats in each AIN125 and AIN25 diet group were switched
to fructose-based diets (FRU125 and FRU25). Thus, there
were 18 rats in each of the four groups.
The body weight, food intake, and water intake of each
rat was recorded daily. Body weight (±0.1 g) was measured
using a top-loading balance. Food intake (±0.1 g) was
based on the difference in weight between food given each
day and food remaining the following day; it was corrected
for spillage, which was collected under each cage. Body
composition was assessed weekly. To accomplish this,
each rat was carried to an adjacent room housing a Bruker
Minispec LF110, placed into a plastic restraining tube, and
then inserted into the core of the machine for ~90 sec
while its body composition was assessed by magnetic
resonance technology. The rat was then returned to its
home cage.
To confirm the development of calcium deficiency,
blood ionized calcium levels were measured on Days 10
and 17, at ~7 h after the start of the light period. Ap-
proximately 70 μl of blood was collected from the tip of
the tail into a heparin-coated capillary tube (RAPIDLyte
Multicap, Siemens) and within 15 sec analyzed using a
Rapidlab 348 blood gas analyzer (Siemens, Germany)
located in the vivarium. For this and subsequent tests,
care was taken to collect blood samples from the rats in
an order that controlled for disturbances and any delays
between sampling and assaying. To do this, the samples
were collected successively from rats in tetradscontaining one representative of each of the four diet
groups, and the order within each tetrad was
counterbalanced.
Fasting blood glucose, insulin and triglyceride (TG) levels
were measured in blood samples collected on Days 11, 18
and 42, at ~7 h after the start of the light period. Taking
into account that young growing rats were relatively small
at the beginning of the experiment we opted to use a
morning fast instead of more severe overnight food
deprivation: In small rodents prolonged overnight fasting
induces a catabolic state, and along with standard housing
conditions at subthermoneutral temperatures it can
decrease metabolic rate [24]. In our experiment, we aimed
to collect measurements under less extreme physiological
conditions. Rats were fasted for 5–6 h and then a blood
sample was collected from the tip of the tail into an
EDTA-treated tube. The tubes were centrifuged and
plasma glucose and TG levels were analyzed using
enzyme-based colorimetric assays (Cayman Chemical, MI).
Insulin levels were measured using ELISA (Rat insulin kit
# EZRMI-13 K, EMD Millipore, MA). Sometimes when
the rats were young, insufficient blood was collected to
conduct all the measurements. In these cases, insulin mea-
surements were given priority.
An oral glucose tolerance test was given between
Days 23–25, at ~7 h after the start of the light
period. After an overnight fast, each rat was gavaged
with 8 ml/kg of 25 % glucose solution (2 g/kg). Blood
was collected at 0, 15, 30, 60 and 120 min. Plasma
glucose and insulin levels were measured as described
above.
An insulin tolerance test (ITT) was given on either
Day 36 or 37, at ~7 h after the start of the light period.
After a 5–6 h fast, each rat received insulin [0.75 IU/kg,
0.75 ml/kg, i.p. of 1 IU insulin (HumilinR, Eli Lilly) solu-
tion prepared in isotonic saline]. For this test, glucose
levels were measured using an Accu-Check Aviva Plus
blood glucose meter (Roche Diagnostics).Data analysis
Body weights were analyzed using weekly measurements
taken on the day of the body composition assessment.
Daily food intakes were averaged into weekly blocks,
based on the sum of daily measurements divided by the
number of days; days when rats were fasted overnight
were excluded from analysis.
Areas under the glucose and insulin curves during
oral glucose tolerance tests were calculated using the
trapezoidal rule [25, 26].
Two-way ANOVAs with factors of Diet Carbohydrate
and Diet Calcium were used to analyze the area under the
glucose and insulin curves. For all other measures, three-
way mixed-design ANOVAs were used, with the same two
ab
c
Fig. 1 Body weight (a), body fat (as a proportion of body weight)
(b), and food intake (c) of rats fed diets differing in carbohydrate
source and calcium content. Symbols with vertical bars represent
means ± SEMs. AIN125–rats fed AIN-93G diet containing 125 mmol
Ca2+/kg, FRU125–rats fed fructose-based diet containing 125 mmol
Ca2+/kg, AIN25–rats fed AIN-93G diet containing 25 mmol Ca2+/kg,
FRU25–rats fed fructose-based diet containing 25 mmol Ca2+/kg. Where
error bars are not shown they were smaller than the symbol size
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tor. When appropriate, differences between pairs of means
were assessed using Fisher LSD tests. The criterion for
statistical significance was p ≤ 0.05.
One animal was excluded from the analyses of the oral
glucose tolerance test due to unsuccessful gavage of the
glucose load. The Week 3 body composition of one rat
was lost due to a technical error.
Results
Body weight and food intake
All four groups of rats gained weight steadily over
the 6 weeks of the experiment, although those fed the
low-calcium diets gained less weight than did those fed
the calcium-replete diets; the difference was statistically
significant at Week 3 and thereafter [Diet Calcium× Time,
F (5,335) = 99.6, p < 0.001]. The source of dietary carbohy-
drate did not affect body weight (Fig. 1a). Dietary calcium
content had an effect on fat accumulation over time (Diet
Calcium×Time, F (5,330) = 4.1, p ≤ 0.05; Fig. 1b): In all
four groups, the proportion of body fat fell from Week 1
to Week 2, but in rats fed the calcium-replete diets the
proportion of body fat increased significantly between
Week 2 and Week 4, whereas in the rats receiving low-
calcium diets a significant increase above the values for
Week 2 did not occur until Week 5 (Fig. 1b). However,
there were no significant differences between rats fed
calcium-replete and low-calcium diet in the proportion of
body fat at any time.
Food intakes reflected the differences in body weight
gain: Starting from Week 3, rats fed the low-calcium diets
ate significantly less food than did rats fed the calcium-
replete diets (Diet Calcium× Time, F (5,335) = 17.9, p <
0.001; Fig. 1c). Fructose affected food consumption on
Weeks 2 and 4 only, when the rats fed the fructose-based
diet ate more food than did the rats fed the AIN diets
[Diet Carbohydrate × Time, F (5,335) = 2.36, p ≤ 0.05].
Fasting blood calcium, insulin, glucose, and TGs
Rats fed the low-calcium diets were hypocalcemic on
Days 10 and 17, F (1,67) = 17.3, p < 0.001, with no differ-
ence between the two measurements, suggesting that
the diets had their intended effects, and that blood ion-
ized calcium concentrations were stable. There was no
effect of the carbohydrate source on blood ionized
calcium concentrations (Table 2).
Rats fed the diets containing fructose had elevated fast-
ing glucose levels and markedly elevated TG levels relative
to rats fed the AIN-based diets [glucose, F (1,62) = 13.4,
p < 0.001; TG, F (1,50) = 36.7, p < 0.001]. There were no
effects of dietary calcium on fasting blood levels of glucose
or TG at any time; however, fasting insulin levels were
lower in rats fed the low-calcium diets than calcium-
replete diets, F (1, 64) = 6.9, p < 0.01. Fructose-fed ratstended to have higher fasting insulin levels than did rats
fed the AIN-based diets, F (1,64) = 3.8, p = 0.06. There was
no interaction between dietary carbohydrate and calcium
[Diet Carbohydrate × Diet Calcium, F (1,64) = 1.9, NS;
Diet Carbohydrate × Diet Calcium× Time, F (2,128) = 0.1,
NS]. All four groups had increasingly higher glucose,
Table 2 Fasting plasma levels of calcium, insulin, glucose and
triglycerides (TG) on various days after introduction of
experimental diets
AIN125 FRU125 AIN25 FRU25
Ca2+, mg/dL***
Day 10 5.60 ± 0.08 5.68 ± 0.08 5.36 ± 0.08 5.28 ± 0.04
Day 17 5.52 ± 0.08 5.60 ± 0.08 5.28 ± 0.08 5.28 ± 0.08
Insulin, ng/mL**§
Day 11 2.0 ± 0.3 2.6 ± 0.3 1.9 ± 0.3 1.9 ± 0.3
Day 18 2.4 ± 0.3 3.3 ± 0.3 2.2 ± 0.3 2.3 ± 0.3
Day 42 4.7 ± 0.5 5.8 ± 0.4 4.0 ± 0.5 4.4 ± 0.5
Glucose, mg/dL#§
Day 11 101 ± 4 109 ± 4 97 ± 4 105 ± 4
Day 18 115 ± 1 126 ± 4 116 ± 4 123 ± 4
Day 42 134 ± 3 143 ± 3 129 ± 3 138 ± 3
TG, mg/dL#§
Day 11 56 ± 15 134 ± 16 48 ± 15 102 ± 14
Day 18 82 ± 16 173 ± 17 61 ± 16 163 ± 15
Day 42 98 ± 18 201 ± 19 75 ± 18 153 ± 16
Data are presented as mean ± SEM of n = 14–18 per group. Blood samples
were collected during the light period, after a 5–6 h fast except for the
calcium measurements when rats were in a fed state. ** - main effect of
Dietary Calcium p < 0.01; ***-main effect of Dietary Calcium p < 0.001; #-main
effect of Diet Carbohydrate p < 0.001; §-main effect of Time
p < 0.001, Day11 < Day18 < Day42
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gressed [effects of Time: glucose, F (2, 124) = 71.9; TG, F
(2, 100) = 20.9; insulin F (2, 128) = 75.6 p < 0.001].
Oral glucose tolerance test
Dietary fructose and calcium had independent and
opposite effects on the elevation of plasma insulin con-
centrations elicited by the oral glucose load: Fructose
feeding increased insulin concentrations whereas the
low-calcium diet decreased them (Fig. 2a; Diet Carbohy-
drate × Time, F (4,240) = 10.2, p < 0.001; Diet Calcium ×
Time, F (4,240) = 8.1, p < 0.001). Calcium-replete rats fed
fructose had an exaggerated insulin response compared
with the other three groups (Fig. 2b, AUC: Diet
Carbohydrate × Diet Calcium, F (1,67) = 4.3, p ≤ 0.05).
The effect of fructose consumption on plasma
glucose concentrations depended on calcium status
(Fig. 2c, Diet Carbohydrate × Diet Calcium × Time, F
(4,236) = 2.5, p ≤ 0.05). The glucose levels of the
FRU125 group were higher than those of the other
three groups at 30 min after gavage, and higher than
those of the AIN125 and AIN25 groups, but not the
FRU25 group, at 15 min after gavage. The plasma
glucose levels of rats fed the FRU25 diet were simi-
lar to those of rats in the other three groups at
every time. The area under the curve was smaller in
rats fed the low-calcium diets than the replete diets,F (1,67) = 3.89, p ≤ 0.05 and was higher in the
fructose-fed rats than in the rats fed AIN-based diets
F (1,67) = 12.6, p < 0.001 (Fig. 2d).
Insulin tolerance test (ITT)
Rats fed the low-calcium diets had lower plasma glucose
concentrations in response to insulin administration, but
this depended on the carbohydrate source (Fig. 3; Diet
Carbohydrate × Diet Calcium× Time, F (5,340) = 2.2, p ≤
0.05). Glucose levels at 15 min after insulin injection were
lower in the rats fed AIN25 diet than in those fed
AIN125. There were no other differences.
Discussion
The results demonstrate that fructose-induced hyperinsu-
linemia and impaired glucose tolerance depend on cal-
cium status: In line with earlier work, plasma insulin
concentrations and blood glucose levels in response to a
glucose load were markedly elevated in calcium-replete
rats fed fructose relative to those fed a standard starch-
and-sucrose mixture [10]. These effects of fructose feeding
were strongly attenuated in rats that received a low-
calcium diet. However, fasting glucose levels in fructose-
fed rats were not improved by low-calcium feeding. Thus,
eating a low-calcium diet significantly alleviated but did
not abolish the effects of fructose feeding on glucose
handling.
Relative to the calcium-replete fructose-fed rats, the
calcium-deficient fructose-fed rats had lower glycemia in
response to a glucose load despite a smaller rise in insu-
lin levels. This implies that the response to insulin is less
affected by fructose overfeeding under conditions of cal-
cium deficiency. The drop in blood glucose levels in re-
sponse to insulin injection was larger in rats that
received the low-calcium version than calcium-replete
version of the AIN-93G diet. This points towards in-
creased insulin sensitivity of the peripheral tissues under
conditions of calcium deficiency.
There are at least two plausible mechanisms by which
calcium deficiency could influence insulin sensitivity.
One involves the activation of insulin receptor expres-
sion by high levels of circulating 1,25-hydroxyvitamin D3
[27–29]. An increase in levels of 1,25-hydroxyvitamin D3
is a classic effect of calcium deficiency, and it has been
observed with the low-calcium diet used here (i.e.,
AIN25 diet; [30, 31]). Activation of insulin receptor
expression through 1,25-hydroxyvitamin D3 action
would counteract the suppression of insulin receptor re-
sponsiveness that is exerted by fructose feeding [32].
The other plausible mechanism involves activation of
the osteoblast-specific factor, osteocalcin. Levels of
circulating osteocalcin, including the active uncarboxy-
lated form, increase when rats are fed low-calcium diets










Fig. 2 Oral glucose tolerance test of rats fed diets differing in carbohydrate source and calcium content. Symbols and bars show means ± SEMs.
AUC–area under the curve, AIN125–rats fed AIN-93G diet containing 125 mmol Ca2+/kg, FRU125–rats fed fructose-based diet containing
125 mmol Ca2+/kg, AIN25–rats fed AIN-93G diet containing 25 mmol Ca2+/kg, FRU25–rats fed fructose-based diet containing 25 mmol
Ca2+/kg; groups sharing the same letter did not differ from each other. Changes in plasma insulin levels (a): *Diet Calcium× Time, p < 0.001; # - Diet
Carbohydrate × Time, p < 0.001. Insulin AUC (b): Diet Carbohydrate x Diet Calcium, p≤ 0.05. Changes in plasma glucose levels (c): 0 no differences; 15:
AIN125a, FRU125b, AIN25a, FRU25ab; 30: AIN125a, FRU125b, AIN25a, FRU25a; 60: AIN125a, FRU125ab, AIN25bab, FRU25abc; 120: AIN125ab, FRU125ab, AIN25a,
FRU25ab; Glucose AUC (d): There were no differences between individual means. Diet Carbohydrate (p < 0.001) and Diet Calcium (p ≤ 0.05)
independently affected the glucose AUC
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osteocalcin improve insulin sensitivity in mice fed high-
fat diet, which is a metabolic challenge comparable in
some of its effects to fructose feeding [36].
Enhanced insulin sensitivity mediated through the
action 1,25-hydroxyvitamin D3 and/or osteocalcin maya
Fig. 3 Insulin tolerance test. Data are means ± SEMs. AUC–area under the c
FRU125–rats fed fructose-based diet containing 125 mmol Ca2+/kg, AIN25–
fructose-based diet containing 25 mmol Ca2+/kg; (a) Changes in plasma gl
No significant differenceshave emerged as an adaptation to conditions when diet-
ary sources of calcium are scarce in order to overcome
the secretory deficiency of pancreatic beta-cells induced
by low calcium levels.
Reduced fasting insulin levels in rats fed low-calcium
diets, and hampered glucose-induced hyperinsulinemiab
urve, AIN125-rats fed AIN-93G diet containing 125 mmol Ca2+/kg,
rats fed AIN-93G diet containing 25 mmol Ca2+/kg, FRU25 – rats fed
ucose levels: *-AIN125b, AIN25a, FRU125ab, FRU25ab. Glucose AUC (b):
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sistent with the effect of dietary calcium deficiency to
interfere with insulin release [14, 15]. Glucose-induced
hyperinsulinemia in fructose feeding may have also been
ameliorated by what appears to be improved insulin
sensitivity in calcium deficiency: Exaggerated insulin
release in fructose feeding is thought to be a compensa-
tory response to the development of insulin resistance in
the periphery and thus could potentially be prevented if
insulin sensitivity is maintained [6].
Insulin sensitivity is tied to body size, particularly body
fat. However, this cannot explain the results found here
because differences in insulin release, and the effects of in-
sulin on blood glucose levels, in rats fed the low-calcium
and the calcium-replete diets were not related to the pro-
portion of adipose tissue: There were no differences in the
proportion of body fat among the experimental groups at
any time.
Several studies suggest that, under some conditions,
calcium-deficient rodents are more susceptible to obesity
than their replete controls [37, 38] but there are also
several failures to observe this [31, 39]. The current
work falls in the latter camp and supports the conclu-
sion that calcium intake has no direct effect on the
development of obesity in rats.Conclusions
The experiments reported here reveal that, in rats, a
low-calcium diet—despite being harmful in its own ways
[40–43]—can counteract the detrimental effects of fruc-
tose overconsumption on glucose handling. If this rela-
tionship applies to humans, then exhortations to consume
more calcium may exacerbate components of metabolic
syndrome. The health outcomes caused by excess con-
sumption of high-fructose corn syrup may be influenced
as much by the calcium status of an individual as by the
amount of the sugar the individual consumes. At the least,
the results point to the complexity of nutritional interac-
tions that make giving dietary advice fraught with peril.Competing interests
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